Bluejay Diagnostics appoints Kenneth Fisher as CFO with $275K salary; Kinder resigns

Bluejay Diagnostics, Inc.

Kenneth Fisher appointed CFO effective March 23, 2022; Gordon Kinder resigned same day.
Employment agreement: $275K annual salary (increases to $300K on Jan 1, 2023), target annual bonus 40% of base.
Received 10-year option for 65,000 shares at $1.31/share; 5,000 vested immediately, 60,000 vest over 3 years.
Severance: six months base salary plus pro rata bonus if terminated without cause.
Fisher's prior role: EVP, CFO and Treasurer of Meridian Bancorp (merged with Rockland Trust in Nov 2021).

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gordon Kinder

Chief Financial Officer

BJDX · Bluejay Diagnostics, Inc.

Effective: 2022-03-23
Successor: Kenneth Fisher
Filed: March 28, 2022, 7:59 PM ET

On March 23, 2022, the Company accepted the resignation of Mr. Gordon Kinder from his position as Chief Financial Officer effective immediately.

Appointed

Kenneth Fisher

Chief Financial Officer

BJDX · Bluejay Diagnostics, Inc.

Effective: 2022-03-23
Filed: March 28, 2022, 7:59 PM ET

On March 23, 2022, Bluejay Diagnostics, Inc. (the “Company”) entered into an employment agreement with Mr. Kenneth Fisher pursuant to which Mr. Fisher agreed to serve as Chief Financial Officer of the Company commencing on such date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gordon Kinder resigned as Chief Financial Officer at Bluejay Diagnostics, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On March 23, 2022, the Company accepted the resignation of Mr. Gordon Kinder from his position as Chief Financial Officer effective immediately.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Kenneth Fisher was appointed as Chief Financial Officer at Bluejay Diagnostics, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On March 23, 2022, Bluejay Diagnostics, Inc. (the “Company”) entered into an employment agreement with Mr. Kenneth Fisher pursuant to which Mr. Fisher agreed to serve as Chief Financial Officer of the Company commencing on such date.

View on SEC.gov

Bluejay Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-015522

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.